Close menu




October 9th, 2020 | 12:37 CEST

BioNTech, Barrick Gold, Velocity Minerals - Golden Times!

  • Investments
Photo credits: pixabay.com

No! The end of the gold price increase has yet to be reached. The problems, which have become even more acute in recent months due to the pandemic, will not disappear overnight. It is understandable that the price of the precious metal will briefly collapse because "Big Donald" is saluting himself, or the helicopter pilot who brought him safely back to the White House after his short, three-day intermezzo in the military hospital. He wants to show that he has quickly left Corona behind him. However, among his many headwinds, the President now faces the US election, the still high number of Covid-19 cases in the US, the rapidly increasing national debt, and the unchecked money printing of the central banks. At least in terms of case numbers, there is positive news from BioNTech. The Corona vaccine candidate, developed by the Mainz-based company, is entering the approval phase.

time to read: 2 minutes | Author: Stefan Feulner
ISIN: CA92258F3007 , US09075V1026 , CA0679011084

Table of contents:


    Gold and gold mines remain attractive

    As a result of the course correction, in addition to the well-known big players from North America such as Newmont, Barrick Gold, or Yamana Gold, smaller companies from the second and third rows are also becoming more attractive again. The chance of a further increase in the price of gold is one thing. An imminent consolidation of the gold market through takeovers could provide for fantasy and thus rising prices.

    Bulgaria - the land of golden opportunities

    The celebration capital "Goldstrand", the ballerina of the Balkans, is likely the first answer you get when you ask about the 7 million inhabitant state at the Black Sea. Besides hard liquor and wild parties, Bulgaria offers much more. As the name "Goldstrand" suggests, Bulgaria is the country with the largest gold deposits in Europe.

    Geologists at the Bulgarian Academy of Sciences have calculated that EUR 150 billion are supposed to lie dormant in Bulgaria's soil. According to the experts, there are 60 gold deposits and deposits of more than 13,000 tons in the Balkan state. In terms of gold production, Bulgaria ranks third behind the Scandinavians, Sweden and Finland.

    Big players are settling

    Due to the rising gold price, large players, chiefly North American players in the gold sector, are increasingly looking for promising alternatives outside their comfort zone. Since 1999 the Canadian billion-dollar company, Dundee Precious Metals, has been operating the "Chelopech Mine", one of the largest gold mines in the world in the west of Bulgaria. The reserves are estimated to be more than 42.7 million ounces of gold. According to the company, the concession for the mine has a 30-year term.

    Great potential for up-and-coming explorers

    Just under 50 km from the "Chelopech Mine" in Kazak, there is further potential in the ground. Velocity Minerals Ltd., a gold exploration and development company, founded in Vancouver, Canada, in 2000, intends to exploit this potential. The company, listed on the stock exchange for almost CAD 50 million, is increasing its focus on the emerging south-east of Bulgaria.

    The company's strategy is to develop a low-cost operation in which multiple projects deliver gold concentrates to an existing central processing facility. Velocity holds a 70% interest in the Tintyava Prospecting License, which includes the most significant Rozino Project to date. It has entered into option agreements to acquire a 70% interest in the Obichnik, Makedontsi, and Sedefche gold projects with Gorubso, an established and respected company.

    Study shows the tremendous scope

    The news flow of the past weeks has been extremely positive. Drilling at the Kazak Zone has returned near-surface and high-grade gold grades. Kazak is situated approximately 2 km south of the Rozino Gold Project. A feasibility study for the Rozino Project was published in August. This study demonstrates the potential of the project with a net present value of CAD 163 million. Two factors illustrate the significant leverage: Firstly, the analysis assumes a gold price of USD 1,500, which is well below the current level. Secondly, new exploration zones, such as "Kazak" are not included in the calculation.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read